Found 9 matching trials
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
PHASE3This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
PHASE3This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)
PHASE2This is a multicenter, randomized, controlled study in women who are having...
Location
Multiple Locations
An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant
PHASE1This is an open-label, randomized, single-dose, single-center, parallel-gro...
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)
PHASE2This is a randomized, double-blind, placebo-controlled, crossover, single c...
Location
Multiple Locations
A Multicenter, Randomized, Controlled Trial of SCH 619734 for the Treatment of Chemotherapy-Induced Nausea and Vomiting (Study P04351AM2)(COMPLETED)
PHASE2This is a Phase 2, randomized, multicenter, parallel-group, double-blind, p...
Location
Multiple Locations
Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
PHASE2The purpose of this phase 2 study is to assess the efficacy and patient sat...
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy
PHASE3This is a Phase 3, multicenter, randomized, parallel-group, double-blind, a...
A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron
NAThis study aims to evaluate the efficacy and safety of a combination regime...
Location
Multiple Locations